Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

Lilly said it will cut the list price for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% in the fourth quarter, which starts in September.

As for QWINT-5, which compared efsitora to daily insulin degludec in Type 1 diabetes patients who need daily basal injection and multiple mealtime doses, Lilly’s long-acting prospect lowered A1C ...

Eli Lilly’s once-weekly insulin injection is just as effective as daily insulin shots for managing A1C levels in diabetes, according to the latest results from two phase 3 clinical trials.

In the 52-week basal insulin naïve study, Lilly said once-weekly efsitora reduced hemoglobin A1C, a biological indicator of blood sugar levels, by 1.31% compared to 1.27% for insulin glargine ...

A pair of late-stage trials found that Eli Lilly’s experimental once-weekly insulin can lower blood sugar as effectively as widely used daily insulins, the drugmaker said Thursday, intensifying ...

Insulin revenue is “effectively immaterial in the wake of incretin and novel candidate prospects,” said David Risinger, a Leerink analyst who covers Lilly, referring to the class of GLP-1 drugs.

Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023 after Eli Lilly and Co on Wednesday said it will cut list prices by 70% for its most commonly prescribed insulin ...

Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products. "The 10 mL [millilter] vials of Humalog® and Insulin Lispro Injection are or will be temporarily out of ...

Drugmaker Eli Lilly warned this week that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a “brief delay in manufacturing.” The 10 ...

PAUL, Minn. — Minnesota has reached a settlement with Eli Lilly and Co. in a price-gouging lawsuit against the country's three biggest insulin manufacturers that guarantees that Minnesotans can ...

Through the settlement, Eli Lilly has agreed to implement a texting system to assist pharmacists and patients to determine eligibility for low-cost insulin, and to alert patients about this low ...